Literature DB >> 30875334

18F-PBR06 PET/CT imaging for evaluating atherosclerotic plaques linked to macrophage infiltration.

He Zhang1,2,3, Jie Xiao1,2,3, Jun Zhou1,2,3, Hui Tan1,2,3, Yan Hu1,2,3, Wujian Mao1,2,3, Zhequan Fu1,2,3, Qingyu Lin1,2,3, Hongcheng Shi1,2,3, Dengfeng Cheng1,2,3.   

Abstract

BACKGROUND: The present study explored the 18 kDa translocator protein radioligand [F]N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline (F-PBR06) targeting macrophages for PET imaging of atherosclerotic plaques and evaluating the vulnerability of atherosclerotic plaques toward rupture.
MATERIALS AND METHODS: F-PBR06 was synthesized using a Synthra RNplus module automatically. RAW264.7 cells were used for cell binding study with F-PBR06. In-vivo micro-PET/CT imaging for ApoE mice and C57 mice was performed 1 h after injection of F-PBR06. CD68 and F480 immunofluorescence stainings were performed in the aorta tissues.
RESULTS: In-vitro cell studies showed uptake of F-PBR06 to RAW264.7 cells. Micro-PET/CT imaging identified the atherosclerotic lesions in the aortic arch of ApoE mice successfully, whereas no signal was observed in C57 mice. The ratio of plaque-to-muscle in ApoE mice of 32 weeks was significantly higher than that in ApoE mice of 22 weeks, which was confirmed by CD68 immunofluorescence staining and F480 immunofluorescence staining.
CONCLUSION: TSPO radioligand F-PBR06 allows noninvasive PET/CT imaging of macrophage-abundant atherosclerotic plaques as well as positive correlation between PET imagings and ex-vivo immunofluorescence staining of plaques in mice with different ages, thereby representing a potential attractive tool for evaluating the vulnerability of atherosclerotic plaques towards rupture.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30875334     DOI: 10.1097/MNM.0000000000000978

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  2 in total

1.  Microliter-scale reaction arrays for economical high-throughput experimentation in radiochemistry.

Authors:  Alejandra Rios; Travis S Holloway; Philip H Chao; Christian De Caro; Chelsea C Okoro; R Michael van Dam
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

2.  In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease.

Authors:  Paolo Zanotti-Fregonara; Clément Morgat; Romain Schollhammer; Sébastien Lepreux; Nicole Barthe; Delphine Vimont; Anne Rullier; Igor Sibon; Xavier Berard; Andrea Zhang; Yasuyuki Kimura; Masahiro Fujita; Robert B Innis
Journal:  EJNMMI Res       Date:  2021-05-05       Impact factor: 3.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.